SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Clarification sought from GlaxoSmithkline Consumer Healthcare

09 Jun 2015 Evaluate

The Exchange has sought clarification from GlaxoSmithkline Consumer Healthcare with respect to news article appearing on Moneycontrol website on June 8, 2015 titled ‘FSSAI orders testing of GSK, ITC fast food brands.’

The above information is a part of company’s filings submitted to BSE.

Glaxo.Cons. Health Share Price

9696.40 0.00 (0.00%)
15-Apr-2020 18:01 View Price Chart
Peers
Company Name CMP
Nestle India 1465.60
Varun Beverages 480.75
Britannia Industries 5421.55
LT Foods 379.70
Hatsun Agro Product 909.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: